Overexpression of the gene cerbb2, which encodes a receptor tyrosine kinase, has been associated with prognosis and response to therapy in several solid tumors. The erbb family of receptors is providing the oncogenic signals necessary to cells to become transformed. Arnold on behalf of the esmo guidelines committee et al. Surgical resection is the only treatment for gastric ca, but in an advanced stage of ca prevents curative resection for most patients. Her2 is a protooncogene encoded by erbb2 on chromosome 17. The symptoms of gastric cancer are not specific and can mimic other nonneoplastic gastroduodenal diseases. Molecular mechanisms underlying erbb2her2 action in. Logic lapatinib optimization study in erbb2 her2 positive gastric cancer. Caracterizacion molecular del cancer gastrico her2 positivo.
Her2 erbb2 status is assessed by testing either biopsy or surgical resection specimens. Cancer cells of this subtype do not express er, progesterone receptor pr, and her2 and are therefore. Erbb2 kinase domain mutations were first reported in 2004 to be present in approximately 4% of unselected lung tumors and in 10% of the adenocarcinoma subtype of lung cancer. In breast tumors the extent of overexpression has a prognostic value, thus. Human epidermal growth factor receptor 2 egfr2her2erbb2 is a transmembrane receptor that stimulates cell proliferation when activated. In gastric cancer the erbb2 her2 expression is associated with a poor prognosis, but. The basallike subtype expresses markers of the basal epithelial layer of normal breast tissue such as keratins 56. Erbb2 kinase domain mutation in a gastric cancer metastasis. Genetic trajectory and immune microenvironment of lung. Gastric cancer is the fourth most common type of cancer causing 800,000 mortalities worldwide each year. Gastric cancer represents one of the most common causes of cancer deaths worldwide. Ihc evaluates membranous protein expression of cancer cells.
Research paper her2 as a prognostic marker in gastric. Vol 388 november 26, 2016 gastric cancer eric van cutsem, xavier sagaert, baki topal, karin haustermans, hans prenen gastric cancer is one of the leading causes of. Lapatinib in combination with weekly paclitaxel in. Esmo clinical practice guidelines for diagnosis, treatment and followup. Recent studies revealed that the kinase domain of the erbb2 gene was mutated in human cancers, including gastric cancer. Prevalence of overexpression of her2 in gastric cancer at the centro medico.
Only in developed oriental countries japan, south korea there. Her2neu, adenocarcinoma gastrico, inmunohistoquimica. The erbb receptors, including the epidermal growth factor receptor egfr, erbb2 also known as her2neu, erbb3 or her3, and erbb4 or her4, are often aberrantly activated in a wide. Erbb2 subtype is characterized by the amplification and overexpression of erbb2 her2 and neighboring genes at 17q12q21 locus. Evaluation of the expression of the oncogene c erbb2 her2 in advanced gastric cancer cases from costa rica. Worldwide, it is the second neoplasia in incidence after lung cancer. Gastric cancer is the leading cause of death from malignancy in chile. It is a member of the her family and consists of four plasma. Effects of a human compact antierbb2 antibody on gastric. Erbb2 is a member of the epidermal growth factor receptor egfr family.
To determine the frequency of her2 gene overexpression and amplification in advanced gastric cancer. Expression of erbb2 cd340, her2, her2, neu, ngl in cancer tissue. One hundred nine advanced gastric cancer biopsy specimens, from 76 men and 33 women aged 67 14 and 62. Evaluation of the expression of the oncogene cerbb2her2. Seom guidelines for the treatment of gastric cancer 2015. In breast cancer erbb2 amplification is both prognostic and.
Lauren classification combined with her2 status is a. Gastric cancer and the biological relevance of her2. Evidence have been accumulated on the role of erbb2 amplification in cancer, while very little is known on the role of point mutations 23. The brazilian consensus on gastric cancer promoted by abcg was designed with the intention to issue guidelines that can guide medical professionals to care for patients with this disease. Overexpression of erbb2, a tyrosine kinase receptor involved in the pathogenesis of several human.
Laurenclassification and human epidermal growth factor receptor 2 her2 status are two important pathological features of gastric cancer patients. In general, gastric cancer has a 5year survival rate of 15% and for patients. The cancer tissue page shows antibody staining of the protein in 20 different cancers. Overexpressionamplification of the her2 gene in advanced gastric cancer is a predictor of response to adjuvant therapy with monoclonal. It is clear that human epidermal growth factor receptor 2 her2 protein overexpression and gene amplification are much more heterogeneous in gastric cancer compared to. Lapatinib in combination with weekly paclitaxel in patients with erbb2 amplified advanced gastric cancer the safety and scientific validity of this study is the responsibility of the. Conoce las diferentes manifestaciones del cancer gastrico. Importancia pronostica y predictiva del estudio del oncogen her2. A phase iii global, blinded study designed to evaluate clinical endpoints and safety of chemotherapy plus. Likewise, kaplan meier survival and disease free interval curves were calculated. Gastric cancer is separated anatomically into true gastric adenocarcinomas and gastrooesophagealjunction adenocarcinomas, and histologically into diffuse and intestinal types. Overexpression of erbb2, a receptorlike tyrosine kinase, is shared by several types of human carcinomas. Gastric cancer is the most common malignancy of the digestive tract.
1185 628 950 914 96 1222 911 1164 647 371 769 421 326 336 1420 393 1239 236 215 212 377 297 255 1458 342 1222 818 264 1256 245 241 1302 557 1107 593 1013 340 1157 672 718 1159 899